Tural, D. And KILIÇKAP, S. 2015. First-Line Crizotinib in ALK-Positive Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8 , 781.

Tural, D., & KILIÇKAP, S., (2015). First-Line Crizotinib in ALK-Positive Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8, 781.

Tural, DENİZ, And SAADETTİN KILIÇKAP. "First-Line Crizotinib in ALK-Positive Lung Cancer," NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8, 781, 2015

Tural, DENİZ And KILIÇKAP, SAADETTİN. "First-Line Crizotinib in ALK-Positive Lung Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8, pp.781, 2015

Tural, D. And KILIÇKAP, S. (2015) . "First-Line Crizotinib in ALK-Positive Lung Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.372, no.8, p.781.

@article{article, author={DENİZ TURAL And author={SAADETTİN KILIÇKAP}, title={First-Line Crizotinib in ALK-Positive Lung Cancer}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2015, pages={781} }